Searched for
ZYDUS THERAPEUTICS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
- Zydus Lifesciences appoints Punit Patel as President & CEO, AmericasBefore joining Zydus, he was the President of Red Oak Sourcing, leading the company's "multibillion-dollar generic portfolio", overseeing a...
- Zydus picks 6.5% in Mylab from Adar Poonawala co for ₹106 CrMylab came into limelight during Covid pandemic when it developed and launched indigenous RT-PCR test kits and platform for diagnosing Covi...
- Zydus' US subsidiary acquires speciality drug asset in USUnder the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...
- Zydus Cadila gets US Food and Drug Administration nod for diabetes medicationOn October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100...
- PM's presence to motivate company in quest to bridge unmet healthcare needs: Zydus CadilaThe Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat' mission and offering the nation safe and efficaciou...
- Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...
- Zydus Cadila acquires six brands from Merck IndiaThe acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.
- Zydus eyes acquisitions to turn consumer arm into Rs 500-cr companyZydus Cadila Group, is looking for an exponential grown of its consumer product subsidiary, Zydus Wellness Ltd (ZWL).
- Cadila buys out Liva in an all-cash dealZydus Group’s Cadila Healthcare has acquired Mumbai-based Liva Healthcare, a mid-sized Indian pharma company with a dermatology-focused pro...
Load More
